ASSESSMENT OF THERAPEUTIC EFFICACY OF SIDDHA FORMULARY DRUG SWASAKASA NEI IN THE MANAGEMENT OF SWASAKASAM (BRONCHIAL ASTHMA)
- Conditions
- Health Condition 1: J45- AsthmaHealth Condition 2: J454- Moderate persistent asthma
- Registration Number
- CTRI/2021/07/035137
- Lead Sponsor
- ational Institute of Siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
INCLUSIONCRITERIA:
1.Age between 18-60 years.
2.Sex: Male, Female & Transgender.
3.Patients with a clinical symptoms of Sneezing, Rhinitis, Dyspnoea, Cough with or without expectoration, Wheeze, Tightness of chest.
4.Wheezing more than 3 weeks.
5.Night time wheezing more than one day/week.
6.Asthma sometimes interferes with normal daily activities.
7.Patients who are willing to take radiological investigation and provide blood for lab investigation.
8.Patients who are willing to estimate volume of air forcibly expired after a deep inspiration by using PFT.
1.Having covid-19 (or) past history of covid-19
2.Restrictive Lung diseases
3.Tuberculosis
4.Emphysema
5.Pleural effusion
6.Pneumothorax
7.Cardiac diseases and Renal diseases
8.Sleep apnea
9.Diabetic mellitus
10.Hypertension
11.Pregnancy
12.Lactation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method